In summary, our data show that the use of Dexa and Rapa, drugs widely used in cancer treatment which promote hyperglycemia, are associated with sensitization of mice and cardiomyocytes to the cytotoxic effects of DXR via the PKA–AMPK–EGR1 pathway. Here, PRKAA2 is linked to cancer.